Corresponding Author: Mohammed K. Ali, MD, MSc, MBA, Emory University, 1518 Clifton Rd, CNR Room 7041, Atlanta, GA 30322 (mkali@emory.edu).
Accepted for Publication: June 16, 2020.
Author Contributions: Dr Ali and Mr Emmert-Fees had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Ali, Chwastiak, Poongothai, Anjana, Shankar, Sridhar, Kosuri, Rao, Tandon, Narayan, Mohan.
Acquisition, analysis, or interpretation of data: Chwastiak, Emmert-Fees, Patel, Sagar, A. Sosale, B. Sosale, Rao.
Drafting of the manuscript: Ali, Emmert-Fees, Patel, Sridhar, Rao.
Critical revision of the manuscript for important intellectual content: Ali, Chwastiak, Poongothai, Emmert-Fees, Patel, Anjana, Sagar, Shankar, Kosuri, A. Sosale, B. Sosale, Rao, Tandon, Narayan, Mohan.
Statistical analysis: Chwastiak, Emmert-Fees, Patel.
Obtained funding: Ali, Rao, Narayan.
Administrative, technical, or material support: Ali, Chwastiak, Poongothai, Anjana, Sagar, Sridhar, B. Sosale, Rao, Tandon.
Supervision: Ali, Poongothai, Shankar, A. Sosale, B. Sosale, Rao, Tandon, Narayan, Mohan.
Conflict of Interest Disclosures: Dr Ali reported receiving a grant from Merck outside the submitted work. No other disclosures were reported.
Group information: Nonauthor Contributions to data collection and conduct of the trial: Executive committee: Mohammed K. Ali, MD, MSc, MBA; Lydia Chwastiak, MD, MPH; Viswanathan Mohan, MD, PhD, DSc; Subramani Poongothai, PhD; Mark L. Hutcheson, BA. Coordinating center: Subramani Poongothai, PhD; Nandakumar Parthasarathy, BPharm; Mark L. Hutcheson, BA. Data management and analysis team: Karl M. F. Emmert-Fees, MSPH; Shivani A. Patel, MPH, PhD; Jeba Rani, MBA. Development of decision support electronic health record software: Cygnis Media (https://www.cygnismedia.com/), Mark L. Hutcheson, BA; Alysse J. Kowalski, MPH, PhD; Mohammed K. Ali, MD, MSc, MBA. Data and safety monitoring board members: K. M. Prasanna Kumar, MBBS, MD, DM (MS Ramaiah Medical College, Bengaluru, India); Pallab Maulik, MD, PhD, MSc (George Institute for Global Health, Delhi, India); N. Sreekumaran Nair, PhD (Manipal University, Manipal, India); Usha Rani Pingali, MBBS, MD (Nizam's Institute of Medical Sciences, Hyderabad, India). Site Investigators and research staff: PI: Nikhil Tandon, MD, PhD; Co-I(s): Rajesh Khadgawat, MD, DM; Rajesh Sagar, MD; Radhika Tandon, MD; care coordinator(s): Chandni Chopra, MSc; Bhanvi Grover, MSc; outcome assessor(s): Tania Bhardwaj, MSc; Priyanka Rawat, MSc. Recruiter/Screener: Jijo Joseph, DipNurs (All India Institute of Medical Sciences, Delhi); PI: Viswanathan Mohan, MD, PhD, DSc. Co-I(s): Radha Shankar, MD; Ranjit M. Anjana, MD, PhD; Sethuraman Jagdish, MBBS, MMed; Pathasarathy Balasubramanian, MBBS; Selvam Kasthuri, MBBS, DDip; care coordinator(s): Bhavani B. Sundari, MSc; Phebegeniya Stephen, MSc; outcome assessor(s): Kulasegaran Karkuzhali, BSc; Vijayaraghavan Prathibha, MBBS, DO, PhD; Ramachandran Rajalakshmi, MBBS, DO, PhD; recruiter/screener: Viswanathan Kannikan, MSc (Dr Mohan’s Diabetes Specialties Center, Chennai); PI: Aravind R. Sosale, MBBS; Co-I(s): Bhavana Sosale, MD; Pooja Rai, DipPsych; care coordinator(s): Raghavan Karthik, BCom, DipCLS; outcome assessor(s): Rangawamy Geethanjali, BPharm; site manager: Sunita K. Somaiah, MD (Diacon Hospital, Diabetes Care and Research Center, Bangalore); PI: Gumpeny R. Sridhar, MD, DM; Co-I(s): Madhu Kosuri, PhD; care coordinator(s): Aruna Sri Sikha, MA; outcome assessor(s): Venkateswarlu Chiramana, PhD; Gumpeny Lakshmi, MD (Endocrine Diabetes Center, Visakapatnam). US Collaborators: Jurgen Unutzer, MD, MPH, MA; Wayne Katon, MD (deceased) (University of Washington); Leslie Johnson, PhD; Nida I. Shaik, PhD, (Emory University); previous contributions by Neil K. Mehta, PhD (University of Michigan); Sue Ruedebusch, RN, CDE (Kaiser Permanente Washington Health Research Institute); and Paul Ciechanowski, MD, MPH (University of Washington).
Funding/Support: This study was funded by the National Institute of Mental Health (grant R01MH100390).
Role of the Funder/Sponsor: The National Institute of Mental Health had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: The INDEPENDENT Study Group thanks all the participating patients.
Data Sharing Statement: See Supplement 3.
1.National Academies of Sciences Engineering and Medicine. Crossing the Global Quality Chasm: Improving Health Care Worldwide. National Academies Press; 2018.
3.Garin
N , Koyanagi
A , Chatterji
S ,
et al. Global multimorbidity patterns: a cross-sectional, population-based, multi-country study.
J Gerontol A Biol Sci Med Sci. 2016;71(2):205-214.
PubMedGoogle ScholarCrossref 4.Arokiasamy
P , Uttamacharya
U , Jain
K ,
et al. The impact of multimorbidity on adult physical and mental health in low- and middle-income countries: what does the Study on Global Ageing and Adult Health (SAGE) reveal?
BMC Med. 2015;13(1):178. doi:
10.1186/s12916-015-0402-8PubMedGoogle ScholarCrossref 8.Sullivan
MD , O’Connor
P , Feeney
P ,
et al. Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy.
Diabetes Care. 2012;35(8):1708-1715.
PubMedGoogle ScholarCrossref 9.Depression and Other Common Mental Disorders: Global Health Estimates. World Health Organization; 2017.
12.World Health Organization; Calouste Gulbenkian Foundation. Integrating the Response to Mental Disorders and Other Chronic Diseases in Health Care Systems. World Health Organization; 2014:6-50.
14.Ali
MK , Singh
K , Kondal
D ,
et al; CARRS Trial Group. Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: a randomized, controlled trial.
Ann Intern Med. 2016;165(6):399-408.
PubMedGoogle ScholarCrossref 15.Kowalski
AJ , Poongothai
S , Chwastiak
L ,
et al. The integrating depression and diabetes treatment (INDEPENDENT) study: design and methods to address mental healthcare gaps in India.
Contemp Clin Trials. 2017;60:113-124.
PubMedGoogle ScholarCrossref 16.Rao
D , Lipira
L , Kumar
S ,
et al. Input of stakeholders on reducing depressive symptoms and improving diabetes outcomes in India: formative work for the INDEPENDENT study.
Int J Noncommunicable Dis. 2016;1(2):65-75.
PubMedGoogle ScholarCrossref 21.Menon
VU , Guruprasad
U , Sundaram
KR ,
et al. Glycaemic status and prevalence of comorbid conditions among people with diabetes in Kerala.
Natl Med J India. 2008;21(3):112-115.
PubMedGoogle Scholar 24.Fitzmaurice
GM , Laird
NM , Ware
JH .
Applied Longitudinal Analysis. 2nd ed. John Wiley & Sons; 2011. doi:
10.1002/9781119513469 25.A language and environment for statistical computing. R Foundation for Statistical Computing website. Last accessed April 2020.
https://www.R-project.org/ 29.Lim
LL , Lau
ESH , Kong
APS ,
et al. Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: a systematic review and meta-analysis.
Diabetes Care. 2018;41(6):1312-1320.
PubMedGoogle ScholarCrossref 30.Lauritzen
T , Griffin
S , Borch-Johnsen
K ,
et al. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening.
Int J Obes Relat Metab Disord. 2000;24(suppl 3):S6-S11. doi:
10.1038/sj.ijo.0801420PubMedGoogle ScholarCrossref 31.Griffin
SJ , Borch-Johnsen
K , Davies
MJ ,
et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.
Lancet. 2011;378(9786):156-167. doi:
10.1016/S0140-6736(11)60698-3PubMedGoogle ScholarCrossref 32.Sandbæk
A , Griffin
SJ , Sharp
SJ ,
et al. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial.
Diabetes Care. 2014;37(7):2015-2023. doi:
10.2337/dc13-1544PubMedGoogle ScholarCrossref 35.Lustman
PJ , Anderson
RJ , Freedland
KE ,
et al. Depression and poor glycemic control: a meta-analytic review of the literature.
Diabetes Care. 2000;23(7):934-942.
PubMedGoogle ScholarCrossref 36.Michie
S , van Stralen
MM , West
R . The behaviour change wheel: a new method for characterising and designing behaviour change interventions.
Implement Sci. 2011;6(1):42.
PubMedGoogle ScholarCrossref 37.Ali
MK , Bullard
KM , Saaddine
JB ,
et al. Achievement of goals in U.S. diabetes care, 1999-2010.
N Engl J Med. 2013;368(17):1613-1624.
PubMedGoogle ScholarCrossref 38.Ali
MK , Bullard
KM , Saydah
S , Imperatore
G , Gregg
EW . Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014.
Lancet Diabetes Endocrinol. 2018;6(5):392-403.
PubMedGoogle ScholarCrossref 39.Renders
CM , Valk
GD , Griffin
S ,
et al. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings.
Cochrane Database Syst Rev. 2001;(1):CD001481.
PubMedGoogle Scholar